NP31424 Clozapine Medicines

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£8K-£4M
Sector
HEALTH
Published
28 Oct 2024
Delivery
not specified
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act

Geochart for 1 buyers and 2 suppliers

1 buyer

1 supplier

Description

Supply of clozapine medicines (alongside four (4) patient testing routes) to NHS Scotland. Goods and Services were split into four (4) categories, each of which identified as a “Lot”. The Authority intended to award a single-supplier Framework Agreement per Lot. Further detail about each Lot is contained in XXXXXXXXXXXXXXXXXXXXX.

Lot Division

1 Clozapine Tablets (Core)

Supply of Clozapine Tablets (Core), alongside three (3) patient testing routes, to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.

Award Criteria
Technical (Services) -- Central Laboratory Testing 12
Technical (Services) -- Local Laboratory Testing 12
Technical (Services) -- Near Patient Testing (General) 12
Technical (Services) -- Training, Educational, and Support Materials 6
Technical (Services) -- Implementation Plan 18
price 40
2 Clozapine Orodispersible Tablets Sugar Free (Non-Core)

Supply of Clozapine Orodispersible Tablets Sugar Free (Non Core), alongside three (3) patient testing routes, to NHS Scotland. The Authority intended to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.

Award Criteria
Technical (Services) -- Central Laboratory Testing 12
Technical (Services) -- Local Laboratory Testing 12
Technical (Services) -- Near Patient Testing (General) 12
Technical (Services) -- Training, Educational, and Support Materials 6
Technical (Services) -- Implementation Plan 18
price 40
3 Clozapine Oral Suspension Sugar Free (Non-Core)

Supply of Clozapine Clozapine Oral Suspension Sugar Free (Non-Care), alongside three (3) patient testing routes, to NHS Scotland. The Authority intended to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.

Award Criteria
Technical (Services) -- Central Laboratory Testing 12
Technical (Services) -- Local Laboratory Testing 12
Technical (Services) -- Near Patient Testing (General) 12
Technical (Services) -- Training, Educational, and Support Materials 6
Technical (Services) -- Implementation Plan 18
price 40
4 Clozapine Tablets (Near Patient Testing (Capillary)) (Non-Core)

Supply of Clozapine Tablets (Near Patient Testing (Capillary)) (Non-Core), alongside one (1) patient testing route, to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.

Award Criteria
Technical (Services) -- Central Laboratory Testing 12
Technical (Services) -- Local Laboratory Testing 12
Technical (Services) -- Near Patient Testing (General) 12
Technical (Services) -- Training, Educational, and Support Materials 6
Technical (Services) -- Implementation Plan 18
Technical (Services) -- Near Patient Testing (Capillary Blood Sampling) 0
price 40

Award Detail

1 Viatris UK Healthcare (Hatfield)
  • Clozapine Tablets (Core)
  • Reference: 034861-2024-1
  • Value: £4,309,695
2 Viatris UK Healthcare (Hatfield)
  • Clozapine Tablets (Near Patient Testing (Capillary)) (Non-Core)
  • Reference: 034861-2024-4
  • Value: £7,901

CPV Codes

  • 33600000 - Pharmaceutical products

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated values referred to in Section II.I.7 and Section V.2.4 (and within all Lots) covers the thirty-six (36) month Framework duration and the twenty-four (24) month extension period of the Framework Agreement. (SC Ref:779612)

Reference

Domains